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Abstract
Background: Lightheadedness, fatigue, weakness, heart palpitations, cognitive dysfunction, muscle pain, and
exercise intolerance are some of the symptoms of orthostatic intolerance (OI). There is substantial comorbidity of OI
in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome). The 10-minute NASA Lean Test (NLT) is a simple,
point-of-care method that can aid ME/CFS diagnosis and guide management and treatment of OI. The objective of
this study was to understand the hemodynamic changes that occur in ME/CFS patients during the 10-minute NLT.
Methods: A total of 150 ME/CFS patients and 75 age, gender and race matched healthy controls (HCs) were enrolled.
We recruited 75 ME/CFS patients who had been sick for less than 4 years (< 4 ME/CFS) and 75 ME/CFS patients sick for
more than 10 years (> 10 ME/CFS). The 10-minute NLT involves measurement of blood pressure and heart rate while
resting supine and every minute for 10 min while standing with shoulder-blades on the wall for a relaxed stance.
Spontaneously reported symptoms are recorded during the test. ANOVA and regression analysis were used to test for
differences and relationships in hemodynamics, symptoms and upright activity between groups.
Results: At least 5 min of the 10-minute NLT were required to detect hemodynamic changes. The < 4 ME/CFS group
had significantly higher heart rate and abnormally narrowed pulse pressure compared to > 10 ME/CFS and HCs.
The < 4 ME/CFS group experienced significantly more OI symptoms compared to > 10 ME/CFS and HCs. The circulatory decompensation observed in the < 4 ME/CFS group was not related to age or medication use.
Conclusions: Circulatory decompensation characterized by increased heart rate and abnormally narrow pulse
pressure was identified in a subgroup of ME/CFS patients who have been sick for < 4 years. This suggests inadequate
ventricular filling from low venous pressure. The 10-minute NLT can be used to diagnose and treat the circulatory
decompensation in this newly recognized subgroup of ME/CFS patients. The > 10 ME/CFS group had less pronounced
hemodynamic changes during the NLT possibly from adaptation and compensation that occurs over time. The
10-minute NLT is a simple and clinically useful point-of-care method that can be used for early diagnosis of ME/CFS
and help guide OI treatment.
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Background
Myalgic encephalomyelitis/chronic fatigue syndrome
(ME/CFS) is a debilitating disease with significant unmet
medical needs that affects as many as 2.5 million people
in the U.S. and causes enormous burden for patients,
their caregivers, the healthcare system and society. The
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symptoms of impaired function accompanied by severe
fatigue, unrefreshing sleep, cognitive impairment and
orthostatic intolerance are worsened by physical and cognitive exertion causing post-exertional malaise (PEM)
[1]. ME/CFS is generally considered to be a post-viral or
post-infection syndrome with immune, metabolic and
neurologic sequelae [2]. Between 84 and 91% of ME/CFS
patients are not yet diagnosed [3]. At least one-quarter of
ME/CFS patients are house- or bedbound at some point
in their lives [4]. The economic impact of ME/CFS is
$17–$24 billion annually for direct costs and $9.1 billion
from lost household and labor force productivity [5, 6].
Orthostatic intolerance (OI) is defined as the development of symptoms during upright posture that are
relieved by lying down or reclining. Lightheadedness,
headache, fatigue, weakness, heart palpitations, tremor
and exercise intolerance are some symptoms of acute OI
[7]. Chronic OI may present even more subtly with nausea, neurocognitive deficits, sensitivity to heat, or sleep
problems [8]. Various physiological irregularities and
syndromes can underlie orthostatic symptoms including postural orthostatic tachycardia syndrome (POTS),
orthostatic hypotension (OH), neurally mediated hypotension and each may have subgroups of their own (i.e.
post-viral POTS, hyperadrenergic POTS, neurogenic
orthostatic hypotension, etc.) [9].
While questions still exist concerning the exact role
of OI in ME/CFS, increasing evidence shows substantial
comorbidity. Indeed, the Institute of Medicine (IOM)
published clinical diagnostic criteria for ME/CFS listing
OI as one of the core features of the illness [1]. Head-up
tilt table testing, and continuous heart rate monitoring
are used in research of OI syndromes. However, neither of these modalities is readily available to clinicians
or easily performed in the clinic. Standardized methods
for point-of-care diagnosis and testing for ME/CFS are
needed.
Simple yet promising bedside tools to acquire orthostatic vital signs are standing or “leaning” tests (done
with shoulders touching a wall for stability), wherein
a patient’s heart rate (HR) and blood pressure (BP) are
measured at set intervals before and after they move
from a supine to standing position. Adoption of practical
point-of-care tests for OI are important to improve ME/
CFS diagnosis, identify possible causes of OI, and direct
treatment options.
Our aim was to determine the utility of the 10-minute NLT as a point-of-care assessment of OI to aid in
ME/CFS diagnosis and to gain an understanding of the
hemodynamic changes associated with OI in ME/CFS.
We found that the 10-minute NLT is easily administered in the clinic and is useful for diagnosing hemodynamic abnormalities that can be treated by physicians.
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Furthermore, use of the 10-minute NLT helped identify
circulatory decompensation in a subgroup of ME/CFS
patients. This is a newly recognized OI subgroup of ME/
CFS patients that can be diagnosed with the 10-minute
NLT and treated appropriately.

Methods
Participants

150 ME/CFS patients who had been seen at Bateman
Horne Center (Salt Lake City, UT) for routine clinical care between February 2018 and September 2019
and 75 matched HCs were recruited for the study.
The 150 MECFS subjects included 75 sick with ME/
CFS for < 4 years (< 4 ME/CFS) and 75 sick for greater
than 10 years (> 10 ME/CFS). The age range of ME/
CFS participants and HCs was 18–65 years at the time
of informed consent. HCs were matched with < 4 ME/
CFS participants by age (± 5 years), gender and ethnicity.
Enrolled ME/CFS participants were required to fulfill the
International Chronic Fatigue Syndrome Study Group
research criteria [10], the Canadian Consensus Criteria
[11], and the IOM clinical diagnostic criteria [1]. HCs
were recruited from the Salt Lake City metropolitan area
using advertisements posted on social media, the clinic
webpage or by phone contact with a volunteer pool from
previous studies. HCs were considered generally healthy
and between 18 and 65 years of age. HCs were excluded
if they fulfilled ME/CFS diagnostic criteria or had a history of illness, had a BMI > 40 or had been treated with
long-term (longer than 2 weeks) antiviral medication
or immune modulatory medications within the past
6 months or had been treated with short-term (less than
2 weeks) antiviral or antibiotic medication within the
past 30 days.
Baseline (Year 1) assessments

All research participants had a physical examination at
the baseline visit in Year 1 that included evaluation of
vital signs, body mass index (BMI), orthostatic vital signs,
skin, lymphatic system, HEENT, pulmonary, cardiac,
abdomen, musculoskeletal, nervous system and fibromyalgia (FM) tender points. Medical history and concomitant medications were documented. The 10-minute
NLT was conducted following the physical examination.
The 10-minute NLT is an orthostatic challenge standing lean test. It requires an exam table, a pulse oximeter
placed on one hand and a blood pressure cuff placed on
the opposite arm. Objective hemodynamic parameters
(i.e. HR and BP) were recorded while subjects were resting supine for 10 min, then moved to a standing position and remained standing for 10 min. Testing requires
at least one person to scribe and monitor HR, signs, and
symptoms and one person to obtain BP measurements.
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Participants were first asked to lie down undisturbed for
10 min. The participant was then asked to stand and lean
against a wall with only shoulder blades touching and
heels 6–8 inches from the wall. BP and HR are recorded
every minute for 10 min and participants were asked to
report any symptoms they experienced.
In addition, all subjects completed the following questionnaires before their baseline visit using REDCap, a
secure and HIPAA compliant electronic data capture
system; DePaul Symptom Questionnaire, Post-Exertional
Fatigue Questionnaire, RAND-36, Fibromyalgia Impact
Questionnaire-R, ACR 2010 Fibromyalgia Criteria Symptom Questionnaire, Pittsburgh Sleep Quality Index, Stanford Brief Activity Survey, Orthostatic Intolerance Daily
Activity Scale, Orthostatic Intolerance Symptom Assessment, Brief Wellness Survey, Hours of Upright Activity,
medical history and family history.
Hemodynamic definitions

Systolic BP (SBP), diastolic BP (DBP) and HR were
used as raw values recorded during the 10-minute NLT.
Pulse pressure (PP) and narrowed pulse pressure (NPP)
were calculated according to the consensus equation:
PP = SBP- DBP and NPP = PP/SBP. PP is considered
abnormally narrow if it is less than 25% of SBP [12]. Subgroup analysis of < 4 and > 10 ME/CFS participants was
conducted. For assessing OI manifestations, changes in
HR and BP during the 10-minute NLT were classified as
follows. OH was defined as a decrease in SBP of 20 mm
Hg or more, or a decrease in DBP of 10 mm Hg or more
in the first 3 min standing compared to resting supine
values. POTS was defined as an increase of HR greater
than 30 bpm or a HR of greater than 120 bpm, based on
the average of the last three minutes standing. (e.g., if
the standing portion of the test was terminated at 6 min,
we calculated the mean of the data recorded during the
3rd, 4th and 5th minutes). This allowed us to include
results from participants unable to complete the 10-minute NLT. OI symptoms were spontaneously reported by
participants during the test. OI signs were observed and
recorded by the scribe. We conceptualized OI symptoms
by identifying and refining common words or concepts
mentioned by participants. To assess the relationship
between self-reported hours of upright activity (HUA)
and hemodynamic changes during the 10-minute NLT,
multiple linear regression was performed between the
average values of hemodynamics data: SBP, DBP, HR, PP,
and NPP in last 3 min standing. Also, additional multiple logistic regression was performed for comparing
hemodynamics between ME/CFS patients with < 5 HUA
and > 5 HUA. HUA is defined as time spent with feet on
the floor (sitting, standing, walking) in the last 24 h.
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Statistical analysis

Data were analyzed by Excel and STATA/MP 13.1 Windows [32-bit] version. All demographic data of subgroups
were compared using ANOVA or T-test, where appropriate. Repeated measures of ANOVA were used to detect
differences in hemodynamic data of each subgroup in
each minute and presented as Means (SD). Fisher’s Exact
test was applied to demonstrate association between
comprehensive hemodynamics trend results in each subgroup. Descriptive statistics used for spontaneous OI
symptom reports. The relationship between the hemodynamic response and HUA was modeled by multiple linear
regression after adjusting for age and gender. Effect modification by medication was evaluated via stratified analyses and tested via the interaction term approach. Logistic
regression was used to analyze HUA. T-test, F-test and
Chi-Square test were used for validating models. A
p-value of < 0.05 was considered statistically significant.

Results
Table 1 shows the baseline demographics and clinical
characteristics of the study participants. The < 4 ME/CFS
participants and HCs were similar in age and > 10 ME/
CFS participants were older (P < 0.005). The distribution of race and gender between the 3 groups was similar. The average HUA was 6.05 (SD ± 4.02) for all ME/
CFS participants. There was a significant difference in
HUA between < 4 ME/CFS and > 10 ME/CFS participants
(5.36 SD ± 3.65 compared to 6.75 SD ± 4.28, P < 0.05). The
baseline HR was significantly different between all ME/
CFS participants and HCs (P < 0.0001) and between < 4
ME/CFS and > 10 ME/CFS (P < 0.05). There was no difference in baseline supine SBP and DBP between groups.
We used the 10-minute NLT to evaluate hemodynamics
in all 225 participants. The > 10 ME/CFS group showed a
higher, increased trend of SBP compared to < 4 ME/CFS
and HCs but the difference was not statistically significant (P > 0.11, Fig. 1). All participants had a similar, sudden increase in DBP immediately after standing. The < 4
and > 10 ME/CFS had significantly greater increases in
DBP after 3 min compared to HCs (P > 0.05, Fig. 2). All
participants had a sudden decrease in PP in the first
minute of standing but there were no significant differences between groups. Abnormal NPP (PP/SBP < 25%)
occurred in the < 4 ME/CFS group after 5 min (< 4 ME/
CFS 24.63% SD ± 7.71, > 10 ME/CFS 26.63% SD ± 7.85,
HCs 27.47% SD ± 7.94, P > 0.11) and by 6 min the < 4 ME/
CFS have statistically significant NPP compared to the
other groups (F2,186 = 5.33, P > 0.006) (Fig. 3). Patients
with ME/CFS demonstrated significant HR increases
every minute compared to HCs even though all subgroups showed continuous HR increases as time standing
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Table 1 Participant characteristics

Age (SD)

HCs (n = 75)

ME/CFS (n = 150)

38.5 (± 14)c

42.1 (± 13)c

< 4 ME/CFS (n = 75)
39.0 (± 13)b

> 10 ME/CFS (n = 75)
45.3 (± 12)b

Race % (n)
White

97 (73)

Other

3 (2)

98 (147)

99 (74)

97 (73)

2 (3)

1 (1)

3 (2)
25 (19)

Gender % (n)
Male

28 (30)

40 (42)

31 (23)

Female

72 (45)

60 (108)

69 (52)

75 (56)

5.36 (± 4)c

6.75 (± 4)c

HUA (SD)

N/A

6.05 (± 4)

Supine vitals (SD)

a

SBP

116.45 (± 15)

116.67 (± 15)

116.21 (± 14)

117.15 (± 15)

DBP

75.54 (± 10)

76.73 (± 10)

76.89 (± 9)

76.57 (± 11)

HR

62.64 (± 11)a

71.25 (± 12)a

73.55 (± 11)c

68.9 (± 12)c

P-Value < 0.0005

b

P-Value < 0.005

c

P-Value < 0.05

Fig. 1 Systolic blood pressure (SBP) changes during the 10-minute NLT. Baseline blood pressure was measured while participants rested supine,
then every minute upon standing for the 10-minute NLT. SBP was not significantly different between the three groups. However, the SBP for > 10
ME/CFS patients was higher than < 4 ME/CFS and HCs and remained high for the duration of the 10-minute NLT

progressed (Fig. 4). The < 4 ME/CFS group had higher
baseline HR compared to > 10 ME/CFS and HCs (< 4 ME/
CFS 73.55 SD ± 11.24, > 10 ME/CFS 68.9 SD ± 12.15, HCs
62.64 SD ± 10.89, F2,220 = 17.18, P > 0.00001) and significantly higher HR compared to > 10 ME/CFS throughout
the 10-minute NLT (P < 0.05). Spontaneous symptoms
of muscle weakness, tingling, dizziness/lightheadedness
and headache were more frequently reported by ME/
CFS patients while HCs reported headache, dizziness,
light headedness, or nausea. Only one HC reported
muscle weakness or tingling. Interestingly, presyncope

and syncope occurred in 12% of HCs and 8% of both < 4
and > 10 ME/CFS participants.
The 10-minute NLT induced OI manifestations of
POTS and OH in 54% of ME/CFS participants and 49%
of HCs (Table 2). Further, HR increased in all groups for
each minute of standing so that by 10 min 33% of HCs,
42% < 4 MECFS and 38% > 10 MECFS met POTS criteria. More ME/CFS participants spontaneously reported
symptoms compared to HCs (P < 0.05). Even though the
rate of POTS was similar among ME/CFS and HCs, significantly fewer HCs reported OI symptoms (P < 0.005).
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Fig. 2 Diastolic blood pressure (DBP) changes during the 10-minute NLT. Baseline blood pressure was measured while participants rested supine,
then every minute upon standing for the 10-minute NLT. All participants had a similar, sudden increase in DBP immediately after standing. (Baseline
DBP: < 4 ME/CFS 76.89 SD ± 8.89, > 10 ME/CFS 76.57 SD ± 10.56, HCs 75.54 SD ± 10.18; DBP after standing 1 min: < 4 ME/CFS 86.55 SD ± 10.69, > 10
ME/CFS 84.11 SD ± 8.74, HCs 83.06 SD ± 10.38). DBP increased significantly for < 4 and > 10 ME/CFS after 3 min standing compared to HCs

Fig. 3 Change in pulse pressure during the 10-NLT. All participants had a sudden decrease in PP in the first minute after transitioning from lying
down to standing. Abnormal NPP, defined as PP/SBP of < 25%, occurred in < 4 ME/CFS patients after 5 min (< 4 ME/CFS 24.63% SD ± 7.71, > 10 ME/
CFS 26.63% SD ± 7.85, HCs 27.47% SD ± 7.94, P > 0.11) and was significantly different from > 10 ME/CFS and HCs 6 min into the 10-minute NLT

Spontaneous OI symptom report in those without POTS
or OH was greater in ME/CFS participants compared to
HCs (P < 0.0005).
We determined whether hemodynamic changes during the 10-minute NLT were due to medication. Similar

results to those shown in Figs. 2 and 4 were found. ME/
CFS participants not taking medications had a significantly higher baseline HR compared to HCs (P < 0.001).
ME/CFS not taking prescription medications for OI had
significantly different DBP (P < 0.009), HR (P < 0.001) and
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Fig. 4 Heart rate changes during the 10-minute NLT. Patients with ME/CFS demonstrated significant HR increases every minute compared to
HCs even though the three groups showed continuous HR increases throughout the 10-minute NLT. Baseline HR and HR throughout the test was
significantly higher for the < 4 ME/CFS group compared to > 10 ME/CFS and HCs

Table 2 OI manifestations during the 10-minute NLT
HCs (n = 75) (%)

ME/CFS (n = 150) (%) < 4 ME/CFS (n = 75) (%)

> 10 ME/CFS (n = 75)
(%)

Hemodynamics
POTS or OH any time sequence

49

54

60

48

POTS or OH last 3 min standing

35

40

47

33

POTS
1 min standing

15

15

12

19

3 min standing

19

25

27

23

5 min standing

23

28

31

26

10 min standing

33

40

42

38

OH
SBP decrease of 20 mm Hg or more

1

6

2

1

DBP decrease of 10 mm Hg or more

0

1

1

0

63c

48c

OI symptoms
OI symptoms reported

a

21a

55a

OI symptoms PLUS signs

b

8

25

31

20

OI signs ONLY

31

27

28

25

OI symptoms ONLY

20a

50a

60

42

POTS with symptoms

33

36

40

32

OH with symptoms

1

3

5

1

P-Value < 0.0005

b

P-Value < 0.005

c

P-Value < 0.05

b
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NPP (P < 0.04) during the last 3 min standing compared
to HCs.
Logistic regression was used to determine whether HR
was predictive of upright activity. A HR increase of 1 beat
per minute resulted in 0.06 HUA decrease (P = 0.002).
Therefore, we would predict HUA would decrease by
1.8 h with a HR increase of 30 beats per minute. Indeed,
HUA decreased 1.4 h in ME/CFS participants with POTS
(P > 0.05, F = 0.17). HUA decreased 2.14 h in those ME/
CFS participants with POTS or OH plus spontaneously
reported symptoms (P = 0.005, F = 0.03). However, having POTS did not predict decreased HUA (P > 0.13,
χ2 = 0.13).

Discussion
Our study demonstrated that the 10-minute NLT is a
simple and meaningful point-of-care test that can be
administered in a clinic setting by trained medical assistants or nurses supervised by a clinician. We also showed
that it takes at least 5 min of standing/leaning to detect
meaningful hemodynamic changes and the full 10 min
are likely to detect more. This is important because physicians generally do 1–3 min of standing in a routine
orthostatic assessment. Van Campen et al. have shown
that abbreviated Tilt Table testing of only 2–5 min misses
a substantial proportion of those ultimately diagnosed
with POTS during a 10-min Tilt Table test [13]. Plash
et al. compared Tilt Test versus Standing hemodynamics in POTS and state that while Tilt Testing produced
larger increases in heart rate, both Tilt and Stand tests
done for 10 min provide meaningful data [14]. Sensitivity
of the 30 bpm criterion was similar for both tests (TILT10 = 93%, STAND10 = 87%), but Specificity was less at
10 min for TILT (40%) than 10 min STAND (67%). They
caution that a diagnosis of POTS should include other
OI criteria and not be based solely on increases in heart
rate regardless of test used. It is important to emphasize
that Tilt Table testing is not readily available to all ME/
CFS patients, and protocols and interpretation of results
differ from center to center. That is why an in-office
10-minute NLT is important. We propose that the objective measurements obtained from the 10-minute NLT are
clinically useful in symptomatic patients regardless of the
cause and provide direction for supportive care. While
it is likely that chronic OI in ME/CFS is compounded by
severe deconditioning, this cannot be the only cause, as
many experience OI from the early onset of disease, even
if fit and active at the time they become ill.
The high occurrence of syncope and increased heart
rate of > 30 bpm in HCs during the 10-minute NLT was
not anticipated but is not surprising. The 10-minute NLT
very effectively removes the “muscle pump” leaving only
the neurovascular response to the completely vertical
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orthostatic stress (that is leaning for 10 min). It is noteworthy that many “healthy” people experience syncope
during head up tilt table testing [15] and tilt table tests are
performed at a 70% angle whereas the 10-minute NLT is
totally vertical. A HR increase of > 30 during the 10-minute NLT was the most common orthostatic change in
vital signs for all subjects. One explanation might be that
all study participants were required to arrive fasting for a
blood draw done about 30 min before the 10-minute NLT
and might explain increased rates across all groups (fasting glucose levels were similar among groups, data not
shown). It is important to emphasize, however, that spontaneous reporting of OI symptoms during the 10-minute
NLT was much more common and diverse in the ME/
CFS patients than HC.
OI is a common chronic complaint in the ME/CFS
population that only occasionally occurs in otherwise
healthy people (usually an acute problem triggered by
heat, dehydration or emotional triggers that are easily
remedied). One clear indicator of the chronic pervasive
nature of OI in ME/CFS is self-reported HUA. Although
HUA data were not collected in healthy controls, one can
estimate at least 12–15 HUA on average in healthy individuals. In this study the average HUA for all ME/CFS
participants was 6 h per 24-h period. The combination of
OI symptoms induced by upright posture with low HUA
in ME/CFS strongly support an underlying chronic disorder of OI. In addition, our study also demonstrates that
the underpinnings of OI in ME/CFS are more complex
than just meeting criteria for POTS.
Higher heart rates (both resting and standing) and
a pathologic drop in pulse pressure stand out as distinguishing markers of illness between the ME/CFS and
HCs. Almost every measured response (other than syncope or presyncope) to orthostatic stress was most dramatic in the < 4 ME/CFS, followed by > 10 ME/CFS and
the least in HC. Blood pressure and heart rate variability have been proposed as potential biomarkers of ME/
CFS. Frith et al. [16] used tilt table testing and identified
blood pressure variability in ME/CFS and proposed it as
a bedside diagnostic tool to measure abnormal hemodynamics. A study that used a 20-min standing test identified heart rate variability as a potential marker of fatigue
in ME/CFS with POTS [17]. The ME/CFS POTS patients
in this study had a shorter duration of illness (average
6 years) compared to the ME/CFS only group (average
10 years). Finally, Richardson et al. [18] used the same
20-min standing test but without hemodynamic assessment and detected an increase in Activin B in ME/CFS
but not in healthy controls in response to the orthostatic
challenge that correlated with ME/CFS disease severity.
This pattern suggests that those with longstanding ME/
CFS illness have adapted to their condition in some ways.
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The striking finding of abnormally narrowed pulse
pressure in the < 4 ME/CFS group suggests a significant drop in ventricular stroke volume while standing
in place that can only be explained by a relative hypovolemia. Typical causes of an abnormally narrowed pulse
pressure are constrictive (cardiac tamponade or restrictive pericarditis), outflow obstruction (aortic or pulmonary stenosis), pump failure from a diseased heart, or
shock (anaphylactic, septic, cardiogenic) [12] and none of
these are present in the ME/CFS patients enrolled in this
study. The pressing research question raised by this study
is what is causing the problem. Small studies that have
not yet been replicated suggest autoantibodies against
adrenergic and muscarinic receptors [19], or a neuroinflammatory process [20] may be playing a role. Invasive
cardiopulmonary exercise test (iCPET) was used to show
that ME/CFS patients have reduced atrial filling pressures and impaired systemic oxygen extraction during
exercise compared to healthy people. This may be related
to abnormal delivery of oxygen due to microscopic left to
right shunt at the tissue level, and/or abnormal cellular
uptake of oxygen [21]. We hypothesize that patients with
ME/CFS have lower tolerance of the perfusion changes
induced by orthostatic stress, from autonomic nervous
system dysregulation in combination with abnormal cellular energy metabolism.
While it isn’t entirely clear why the > 10 ME/CFS group
appear to tolerate the orthostatic stress better than < 4
ME/CFS in terms of a dramatic drop in pulse pressure,
that does not prove they aren’t experiencing a drop in
cerebral perfusion. It is possible that after many years
of ME/CFS illness there is gradual adaptation of the circulatory stress response to upright posture. That may
also explain why the > 10 ME/CFS had the highest rise
in SBP during the 10-minute NLT. There is also an age
difference between the < 4 and > 10 ME/CFS groups of
about 5–6 years which might also explain the higher SBP
response in the > 10 ME/CFS subgroup. A very important recently published study demonstrated that cerebral
blood flow is reduced in ME/CFS during head-up tilt
testing even in the absence of hypotension or tachycardia
[22]. This is consistent with our findings and may explain
why ME/CFS patients were not much more likely to meet
standard criteria for POTS or OH than the HCs, even
though they still became more symptomatic during the
10-minute NLT.
This study has limitations. The study originally aimed
to recruit 150 ME/CFS patients sick for < 4 years and
was amended after 1 year to recruit 75 < 4 and 75 > 10
ME/CFS for comparison. By this time the HCs had been
recruited and matched with the < 4 year ME/CFS. This
is why the > 10 ME/CFS group is older and not matched
with HCs. Participants were not required to taper off all
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medications in advance of the 10-minute NLT, although
many did not take their morning medications due to
fasting for the blood draw. This should potentially have
blunted the response to the 10-minute NLT making
the problem look less severe, or conversely, by skipping
morning meds and fasting, may have caused rebound
symptoms making the results look worse. It is unclear
why ME/CFS on OI medications had more severe OI
findings, but it’s possible that more severe underlying OI
led to the use of these medications as well as a more dramatic response to withholding meds for the fasting blood
draw.

Conclusion
In conclusion, the use of the point-of-care 10-minute
NLT identified circulatory decompensation in a subgroup
of ME/CFS patients sick for < 4 years. The 10-minute
NLT is a simple, in-office assessment that can be used for
early diagnosis and management of ME/CFS. The most
important take-home clinical message from this study is
that the identification of OI in ME/CFS will immediately
provide information for objectively supported diagnoses
and evidence-based targeted treatment, drawing from a
large literature regarding OI and POTS, even if the cause
is unknown.
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